Free Trial
OTCMKTS:NVZMY

Novozymes A/S (NVZMY) Stock Price, News & Analysis

$62.61
+0.04 (+0.06%)
(As of 07/26/2024 ET)
Today's Range
$62.12
$62.63
50-Day Range
$58.40
$63.54
52-Week Range
$38.75
$63.89
Volume
4,335 shs
Average Volume
14,100 shs
Market Capitalization
$29.32 billion
P/E Ratio
39.63
Dividend Yield
0.91%
Price Target
N/A

Novozymes A/S MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.00mentions of Novozymes A/S in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
17.03%
From $1.82 to $2.13 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.57 out of 5 stars

NVZMY stock logo

About Novozymes A/S Stock (OTCMKTS:NVZMY)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

NVZMY Stock Price History

NVZMY Stock News Headlines

Novozymes A/S B (NSISb)
Novozymes A/S (NSISBC.XC)
We’re in a code red crisis and 99% of Americans are clueless
Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
Novonesis AS's Dividend Analysis
DuPont’s stock jumps on dividend hike, stock buyback
We’re in a code red crisis and 99% of Americans are clueless
Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
Major shareholder announcement
Novozymes A/S goes ex-dividend tomorrow
Novozymes's Earnings: A Preview
See More Headlines
Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/31/2024
Ex-Dividend for 5/20 Dividend
5/01/2024
Dividend Payable
5/20/2024
Today
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMY
Employees
6,756
Year Founded
2000

Profitability

Net Income
$439.08 million
Pretax Margin
21.84%

Debt

Sales & Book Value

Annual Sales
$2.60 billion
Cash Flow
$0.95 per share
Book Value
$4.45 per share

Miscellaneous

Free Float
N/A
Market Cap
$29.32 billion
Optionable
Not Optionable
Beta
0.89

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Ms. Ester Baiget (Age 53)
    President & CEO
    Comp: $2.8M
  • Mr. Rainer Lehmann (Age 49)
    Executive VP & CFO
    Comp: $754.29k
  • Mr. Anders Lund (Age 51)
    Chief Operating Officer
    Comp: $913.85k
  • Mr. Claus Crone Fuglsang (Age 56)
    Chief Scientific Officer
  • Mr. Tobias Cornelius Bjorklund
    Head of Investor Relations
  • Ms. Winnie Hoejvang Bugel (Age 59)
    General Counsel of Legal
  • Mr. Tue Micheelsen
    Vice President of Global Sales & Marketing
  • Mr. Morten Enggaard Rasmussen (Age 48)
    Executive Vice President of People & Stakeholder Relations
  • Ms. Tina Sejersgaard Fano (Age 55)
    Executive Vice President of Planetary Health Biosolutions
    Comp: $899.35k
  • Ms. Amy Byrick (Age 50)
    Executive Vice President of Human Health Biosolutions

NVZMY Stock Analysis - Frequently Asked Questions

How have NVZMY shares performed this year?

Novozymes A/S's stock was trading at $54.9050 at the start of the year. Since then, NVZMY shares have increased by 14.0% and is now trading at $62.61.
View the best growth stocks for 2024 here
.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMY) released its quarterly earnings results on Wednesday, January, 31st. The biotechnology company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.47 by $0.11. The biotechnology company earned $664.46 million during the quarter. Novozymes A/S had a trailing twelve-month return on equity of 21.42% and a net margin of 16.88%.

Does Novozymes A/S have any subsidiaries?

Novozymes A/S subsidiaries include these companies: PrecisionBiotics Group Limited, OrganoBalance GmbH, Pacific Vet Group-USA, Allopartis, TJ Technologies, Iogen Bio-Products, Natural Industries, and more.

How do I buy shares of Novozymes A/S?

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NVZMY) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners